Works by D’Alessandria, Calogero


Results: 76
    1
    2
    3
    4

    Thyroid Cancer Imaging In Vivo by Targeting the Anti-Apoptotic Molecule Galectin-3.

    Published in:
    PLoS ONE, 2008, v. 3, n. 11, p. 1, doi. 10.1371/journal.pone.0003768
    By:
    • Bartolazzi, Armando;
    • D'Alessandria, Calogero;
    • Parisella, Maria Gemma;
    • Signore, Alberto;
    • del Prete, Fabrizio;
    • Lavra, Luca;
    • Braesch-Andersen, Sten;
    • Massari, Roberto;
    • Trotta, Carlo;
    • Soluri, Alessandro;
    • Sciacchitano, Salvatore;
    • Scopinaro, Francesco
    Publication type:
    Article
    5

    Prognostic <sup>18</sup>F-flotufolastat PET parameters for outcome assessment of <sup>177</sup>Lu-labeled PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2041, doi. 10.1007/s00259-024-07003-2
    By:
    • Karimzadeh, Amir;
    • Hansen, Kimberley;
    • Hasa, Ergela;
    • Haller, Bernhard;
    • Heck, Matthias M.;
    • Tauber, Robert;
    • D'Alessandria, Calogero;
    • Weber, Wolfgang A.;
    • Eiber, Matthias;
    • Rauscher, Isabel
    Publication type:
    Article
    6
    7
    8
    9

    The Impact of PSMA PET--Based Eligibility Criteria Used in the Prospective Phase II TheraP Trial in Metastatic Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen--Targeted Radioligand Therapy.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 8, p. 1252, doi. 10.2967/jnumed.122.265346
    By:
    • Karimzadeh, Amir;
    • Heck, Matthias;
    • Tauber, Robert;
    • Solaris, Esteban;
    • Nekolla, Stephan;
    • Knorr, Karina;
    • Haller, Bernhard;
    • D'Alessandria, Calogero;
    • Weber, Wolfgang A.;
    • Eiber, Matthias;
    • Rauscher, Isabel
    Publication type:
    Article
    10

    Safety and Efficacy of [<sup>177</sup>Lu]-PSMA-I&T Radioligand Therapy in Octogenarians with Metastatic Castration-Resistant Prostate Cancer: Report on 80 Patients over the Age of 80 Years.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 8, p. 1244, doi. 10.2967/jnumed.122.265259
    By:
    • Tauber, Robert;
    • Knorr, Karina;
    • Retz, Margitta;
    • Rauscher, Isabel;
    • Grigorascu, Sonia;
    • Hansen, Kimberley;
    • D'Alessandria, Calogero;
    • Wester, Hans-Jürgen;
    • Gschwend, Jürgen;
    • Weber, Wolfgang;
    • Eiber, Matthias;
    • Langbein, Thomas
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Pre-therapeutic comparative dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA-I&T in patients with metastatic castration resistant prostate cancer (mCRPC).

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262671
    By:
    • Feuerecker, Benedikt;
    • Chantadisai, Maythinee;
    • Allmann, Anne;
    • Tauber, Robert;
    • Allmann, Jakob;
    • Steinhelfer, Lisa;
    • Rauscher, Isabel;
    • Wurzer, Alexander;
    • Wester, Hans-Jürgen;
    • Weber, Wolfgang A;
    • d'Alessandria, Calogero;
    • Eiber, Matthias
    Publication type:
    Article
    23

    Detection efficacy of <sup>18</sup>F‐rhPSMA‐7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.260091
    By:
    • Rauscher, Isabel;
    • Karimzadeh, Amir;
    • Schiller, Kilian;
    • Horn, Thomas;
    • D`Alessandria, Calogero;
    • Franz, Charlott;
    • Wörther, Hannah;
    • Nguyen, Noemi;
    • Combs, Stephanie E.;
    • Weber, Wolfgang A.;
    • Eiber, Matthias
    Publication type:
    Article
    24

    Pre-therapeutic comparative dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA-I&T in patients with metastatic castration resistant prostate cancer (mCRPC).

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262671
    By:
    • Feuerecker, Benedikt;
    • Chantadisai, Maythinee;
    • Allmann, Anne;
    • Tauber, Robert;
    • Allmann, Jakob;
    • Steinhelfer, Lisa;
    • Rauscher, Isabel;
    • Wurzer, Alexander;
    • Wester, Hans-Jürgen;
    • Weber, Wolfgang A.;
    • d’Alessandria, Calogero;
    • Eiber, Matthias
    Publication type:
    Article
    25

    Detection efficacy of 18F‐rhPSMA‐7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.260091
    By:
    • Rauscher, Isabel;
    • Karimzadeh, Amir;
    • Schiller, Kilian;
    • Horn, Thomas;
    • D`Alessandria, Calogero;
    • Franz, Charlott;
    • Wörther, Hannah;
    • Nguyen, Noemi;
    • Combs, Stephanie E.;
    • Weber, Wolfgang A.;
    • Eiber, Matthias
    Publication type:
    Article
    26

    Pre-therapeutic comparative dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA-I&T in patients with metastatic castration resistant prostate cancer (mCRPC).

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262671
    By:
    • Feuerecker, Benedikt;
    • Chantadisai, Maythinee;
    • Allmann, Anne;
    • Tauber, Robert;
    • Allmann, Jakob;
    • Steinhelfer, Lisa;
    • Rauscher, Isabel;
    • Wurzer, Alexander;
    • Wester, Hans-Jürgen;
    • Weber, Wolfgang A.;
    • d’Alessandria, Calogero;
    • Eiber, Matthias
    Publication type:
    Article
    27

    Detection efficacy of <sup>18</sup>F‐rhPSMA‐7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.260091
    By:
    • Rauscher, Isabel;
    • Karimzadeh, Amir;
    • Schiller, Kilian;
    • Horn, Thomas;
    • D`Alessandria, Calogero;
    • Franz, Charlott;
    • Wörther, Hannah;
    • Nguyen, Noemi;
    • Combs, Stephanie E.;
    • Weber, Wolfgang A.;
    • Eiber, Matthias
    Publication type:
    Article
    28
    29

    Detection efficacy of <sup>18</sup>F-rhPSMA-7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.260091
    By:
    • Rauscher, Isabel;
    • Karimzadeh, Amir;
    • Schiller, Kilian;
    • Horn, Thomas;
    • D'Alessandria, Calogero;
    • Franz, Charlott;
    • Wörther, Hannah;
    • Nguyen, Noemi;
    • Combs, Stephanie E.;
    • Weber, Wolfgang A.;
    • Eiber, Matthias
    Publication type:
    Article
    30

    Detection efficacy of <sup>18</sup>F-rhPSMA-7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.260091
    By:
    • Rauscher, Isabel;
    • Karimzadeh, Amir;
    • Schiller, Kilian;
    • Horn, Thomas;
    • D'Alessandria, Calogero;
    • Franz, Charlott;
    • Wörther, Hannah;
    • Nguyen, Noemi;
    • Combs, Stephanie E.;
    • Weber, Wolfgang A.;
    • Eiber, Matthias
    Publication type:
    Article
    31

    Detection efficacy of <sup>18</sup>F-rhPSMA-7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.260091
    By:
    • Rauscher, Isabel;
    • Karimzadeh, Amir;
    • Schiller, Kilian;
    • Horn, Thomas;
    • D'Alessandria, Calogero;
    • Franz, Charlott;
    • Wörther, Hannah;
    • Nguyen, Noemi;
    • Combs, Stephanie E.;
    • Weber, Wolfgang A.;
    • Eiber, Matthias
    Publication type:
    Article
    32

    Detection efficacy of <sup>18</sup>F-rhPSMA-7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.260091
    By:
    • Rauscher, Isabel;
    • Karimzadeh, Amir;
    • Schiller, Kilian;
    • Horn, Thomas;
    • D'Alessandria, Calogero;
    • Franz, Charlott;
    • Wörther, Hannah;
    • Nguyen, Noemi;
    • Combs, Stephanie E.;
    • Weber, Wolfgang A.;
    • Eiber, Matthias
    Publication type:
    Article
    33

    Positive predictive value and correct detection rate of <sup>18</sup>F-rhPSMA-7 PET in biochemically recurrent prostate cancer validated by composite reference standard.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.255661
    By:
    • Chantadisai, Maythinee;
    • Buschner, Gabriel;
    • Krönke, Markus;
    • Rauscher, Isabel;
    • Langbein, Thomas;
    • Nekolla, Stephan G.;
    • Schiller, Kilian;
    • Heck, Matthias M.;
    • Maurer, Tobias;
    • Wurzer, Alexander;
    • Wester, Hans-Juergen;
    • D'Alessandria, Calogero;
    • Weber, Wolfgang;
    • Eiber, Matthias
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Modeling and Predicting Tumor Response in Radioligand Therapy.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 1, p. 65, doi. 10.2967/jnumed.118.210377
    By:
    • Kletting, Peter;
    • Thieme, Anne;
    • Eberhardt, Nina;
    • Rinscheid, Andreas;
    • D’Alessandria, Calogero;
    • Allmann, Jakob;
    • Wester, Hans-Jürgen;
    • Tauber, Robert;
    • Beer, Ambros J.;
    • Glatting, Gerhard;
    • Eiber, Matthias
    Publication type:
    Article
    47
    48

    Radiation Dosimetry for <sup>177</sup>Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions.

    Published in:
    Journal of Nuclear Medicine, 2017, v. 58, n. 3, p. 445, doi. 10.2967/jnumed.116.178483
    By:
    • Shozo Okamoto;
    • Thieme, Anne;
    • Allmann, Jakob;
    • D’Alessandria, Calogero;
    • Maurer, Tobias;
    • Retz, Margitta;
    • Tauber, Robert;
    • Heck, Matthias M.;
    • Wester, Hans-Juergen;
    • Tamaki, Nagara;
    • Fendler, Wolfgang P.;
    • Herrmann, Ken;
    • Pfob, Christian H.;
    • Scheidhauer, Klemens;
    • Schwaiger, Markus;
    • Ziegler, Sibylle;
    • Eiber, Matthias
    Publication type:
    Article
    49

    Tumor Uptake of Anti-CD20 Fabs Depends on Tumor Perfusion.

    Published in:
    Journal of Nuclear Medicine, 2016, v. 57, n. 12, p. 1971, doi. 10.2967/jnumed.116.176784
    By:
    • Mendler, Claudia Theresa;
    • Feuchtinger, Annette;
    • Heid, Irina;
    • Aichler, Michaela;
    • D'Alessandria, Calogero;
    • Pirsig, Sabine;
    • Blechert, Birgit;
    • Wester, Hans-Jürgen;
    • Braren, Rickmer;
    • Walch, Axel;
    • Skerra, Arne;
    • Schwaiger, Markus
    Publication type:
    Article
    50